|
*New! ADNI press release from the National Institutes of Health (NIH).
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a $60 million, 5 year public-private partnership to test whether repeated imaging tests, biological markers and clinical assessments can be combined to measure the progression of mild cognitive impairment and early Alzheimer’s disease.
Who is eligible to participate?
Individuals age 55 to 90 with and without memory problems are eligible to participate in the study.
What happens at the visits?
Participants will come into Boston University Medical Center approximately every six months for 2-3 years where they will have MRI scans, their blood drawn, and clinical exams including memory testing. Participants will also have the opportunity to be involved in other imaging and biomarker tests such as PET scans and lumbar punctures.
Where is the study taking place?
Boston University Medical Campus
How can I find out more?
This study is no longer open to enrollment. For more information on how to participate in other studies, please call Stephanie Sikora at 617-414-1078.
Frequently Asked Questions About the Alzheimer's Disease Neuroimaging Initiative
Key Personnel
|
